TEBPP_Cover

Topics in Evidence-Based Pharmacy Practice is a continually updated collection of features and editorials that review, examine, and comment on the overload of information in the pharmacy field. Features are reviews of clinical trials, studies, and guidelines that examine the validity of approach, methodology, results, and recommendations, and make recommendations that can affect decision making. Editorials allow leading and emerging minds in the field express their opinion on the ever-changing world of pharmacy practice. Read more...

About the Editors

7/10/2018 11:35:11 AM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Treating Depression: Transcranial Direct-Current Stimulation (tDCS) versus Escitalopram Carolyn Taylor, PharmD candidate, Dawn Havrda, PharmD, BCPS, FCCP
7/10/2018 11:35:11 AM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Does the Addition of Palifosfamide to Carboplatin and Etoposide Improve Survival in Small Cell Lung Cancer? The MATISSE Trial Carrolyn Kate Cowey, PharmD candidate, Bradi L. Frei, PharmD, MSc, BCPS, BCOP
7/6/2018 1:28:29 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Role of Empagliflozin in Type 2 Diabetes for the Prevention of Cerebrovascular Events Su Ngo, PharmD candidate 2018, Dawn Havrda, PharmD, BCPS, FCCP
7/6/2018 1:28:29 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Shorter and Shorter: Is 8 Weeks Enough to Treat HCV Infection? Christine Starrs, PharmD candidate 2018, Jennifer Andres, PharmD, BCPS
6/28/2018 12:01:27 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Metformin in Chronic Renal Disease: Can an Effective Therapy Be Continued Without Risk? Dawn Havrda, PharmD, BCPS, FCCP
6/28/2018 12:01:27 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Rivaroxaban or Aspirin for Secondary Prevention of Cardiovascular Events Dawn Havrda, PharmD, BCPS, FCCP
6/5/2018 11:37:57 AM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Febuxostat vs. Allopurinol and Cardiovascular Safety Dawn Havrda, PharmD, BCPS, FCCP
6/5/2018 11:37:57 AM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Can Prazosin Make the Nightmares Stop in Post-Traumatic Stress Disorder? Dawn Havrda, PharmD, BCPS, FCCP
3/8/2018 2:26:11 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Potential Use of Buprenorphine in Neonatal Abstinence Syndrome Cynthia Bui, PharmD/MBA Candidate, Dawn Havrda, PharmD, BCPS, FCCP
3/8/2018 2:26:11 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Preventing Trastuzumab-Mediated Cardiotoxicity: The MANTICORE 101-Breast Trial Michael Fusco, PharmD candidate, Marcia Brackbill, PharmD, BCPS
1/31/2018 2:55:15 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Antibiotic Therapy in Comatose Mechanically Ventilated Patients Post-Aspiration: To Use or Not to Use Shameen Shrestha, PharmD candidate 2018, Dawn Havrda, PharmD, BCPS, FCCP
1/31/2018 2:55:15 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Choosing the Most Effective Agent for Extended Treatment of Venous Thromboembolism: Rivaroxaban or Aspirin? Cassandra R. Robertson, PharmD candidate, Bobbi Hilker, PharmD, CACP, BCPS
1/10/2018 2:43:57 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC The Controversy of Adjunctive Therapy for Primary Percutaneous Coronary Intervention: HEAT-PPCI Trial Heparin versus Bivalirudin Maryam Moghimi, PharmD candidate, Dawn Havrda, PharmD, BCPS, FCCP
1/10/2018 2:43:57 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Tranexamic Acid in Post-Partum Hemorrhage: How Early Should It Be Administered to Prevent Serious Outcomes? Trung-Anh Le, PharmD candidate, Nga-Lai Poon, PharmD candidate, Dawn Havrda, PharmD, BCPS, FCCP
11/1/2017 1:26:53 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Primary Prevention Statin Therapy in Older Adults—Does the Benefit Remain? Mikella Graham, PharmD candidate, Dawn Havrda, PharmD, BCPS, FCCP
11/1/2017 1:26:53 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC MONALEESA-2: Ribociclib and Letrozole for First-Line Therapy of HR-Positive Advanced Breast Cancer Chelsea Minor, PharmD, Bradi L. Frei, PharmD, BCOP, BCPS
11/1/2017 1:26:53 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Effectiveness of Lixisenatide as Adjunct Therapy for Patients Not at Goal on Metformin: GetGoal-M Trial Kacy Terry, PharmD Candidate, Dawn Havrda, PharmD, BCPS, FCCP
11/1/2017 1:26:53 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Salvaging a Hepatitis C Cure in Treatment-Experienced Patients Ashley DePuy, PharmD, Jennifer Andres, PharmD, BCPS
10/18/2017 1:52:07 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC The Benefit of Switching From a Newer P2Y12 Inhibitor to Clopidogrel 1 Month Post-Acute Coronary Syndrome Christina Lew, PharmD Candidate, Dawn Havrda, PharmD, BCPS, FCCP
10/18/2017 1:52:07 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Evaluating the Use of Direct Oral Anticoagulants in Patients of Extreme Body Weight Alayna Ribovich, PharmD Candidate, Dawn Havrda, PharmD, BCPS, FCCP
8/15/2017 12:32:33 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Painting the Case for Canagliflozin Therapy: The CANVAS Program Jasmine Bryant, PharmD candidate, Rebecca A. Falter, PharmD, BCACP
8/15/2017 12:32:33 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Can We OPTIMIZE Zoledronic Acid Use for Breast Cancer Patients With Bone Metastases? Shelley S. Glaess, PharmD, Bradi L. Frei, PharmD, MSc, BCPS, BCOP
8/2/2017 12:10:51 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Evolocumab Plus Statin Therapy: How Low Can LDL Go and Provide Cardiovascular Benefit? Dawn Havrda, PharmD, BCPS, FCCP
8/2/2017 12:10:51 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Could Rivaroxaban Safely Replace Aspirin Post-acute Coronary Syndrome? Dawn Havrda, PharmD, BCPS, FCCP
7/11/2017 12:15:56 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Preventing C. diff Recurrence—Does the Choice of Antibiotic Matter? Dawn Havrda, PharmD, BCPS, FCCP

About the Editors

William D. Linn, PharmD

Founding Editor

William D. Linn, PharmD, is the Assistant Dean and Chair of the Department of Pharmacy Practice in the Feik School of Pharmacy at the University of the Incarnate Word. He is also the senior editor of Pharmacotherapy in Primary Care, and has served as a clinical specialist in primary care for over twenty years at the South Texas Veterans Health Care System.

Dawn Havrda, PharmD, FCCP, BCPS

Senior Editor

Dawn E. Havrda, Pharm.D., FCCP, BCPS is the Associate Dean for Academic Affairs and Assessment at the University of Tennessee Health Science Center College of Pharmacy.

Nada Al-Qadheeb, PharmD, BCPS, FCCP

Editor

Dr. Al-Qadheeb is a clinical specialist in the Medical and Surgical intensive care unit at King Faisal Specialist Hospital and Research Center (KFSH&RC). She received a BS degree in pharmacy from King Saud University, Riyadh, Saudi Arabia and the Doctor of Pharmacy from University of Maryland, Baltimore. Dr. Al-Qadheeb completed a specialty residency in Critical Care from The Johns Hopkins Hospital, Baltimore. She is board certified in pharmacotherapy and a fellow of the American College of Chest Physicians. She is the recipient of the Dumez Lecture Award for superior professionalism in pharmacy from the University of Maryland, Baltimore. Dr. Al-Qadheeb has several national and international presentations. Her research interests focus on the areas of critical care and infectious diseases.